Kelsy Ketchum on Muck Rack

Kelsy Ketchum

Verified
Philadelphia
As seen in: 360Dx, GenomeWeb, The Minnesota Star Tribune, The Charlotte Observer, Pioneer Press, The News & Observer, The State, Columbus Ledger-Enquirer, Duluth News Tribune, The Modesto Bee, Centre Daily Times, Modern Healthcare and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kelsy

Contact Kelsy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Guardant Health Dodges Additional Damages in TwinStrand Bio, U of Washington Patent Suit

|
By Kelsy Ketchum 
| 360Dx
NEW YORK – In a decision handed down on Tuesday by the US District Court for the District of Delaware, Guardant Health dodged trebled damages in a patent infringement case involving TwinStrand Biosciences and the University of Washington, However, Guardant's motion for judgment as a matter of law or a new trial was denied, and TwinStrand was awarded a request for ongoing royalties at an ongoing royalty rate of 6 percent.
Open in Who Shared Issue with article?

Foundation Medicine Rebrands Saga Diagnostics MRD Test, Seeks New Indications

|
By Kelsy Ketchum 
| GenomeWeb
NEW YORK – After its $595 million acquisition of Saga Diagnostics earlier this year, Roche and its subsidiary Foundation Medicine have rebranded Saga's flagship minimal residual disease test and are aiming for new indications beyond its initial application in breast cancer. The test, previously called Pathlight MRD and now rebranded as FoundationOne MRD to align with Foundation's test portfolio, uses patient tissue from biopsy or resection to extract DNA and perform a full genome sequence.
Open in Who Shared View Duplicates (3) Issue with article?

A Decade in the Making, Tampon-Based Endometrial Cancer Test Validated by Abbott Original

|
By Kelsy Ketchum 
| GenomeWeb
NEW YORK – A new test from Abbott, developed in collaboration with the Mayo Clinic, uses a self-administered tampon to collect samples to test for endometrial cancer.
Open in Who Shared View Duplicates (2) Issue with article?
See all 683 articles

Actions

Share this page

Get in touch with Kelsy

Contact Kelsy, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified